[Form 4] Qorvo, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Chris Koopmans, a director of Qorvo, Inc. (QRVO), acquired 2,496 shares of the company on 08/14/2025, increasing his beneficial ownership to 3,833 shares. The Form 4 was filed under Section 16 and signed by an authorized person on 08/15/2025. The reported acquisition shows a price of $0 for the transaction as recorded on the form.

Positive

• Director Chris Koopmans increased his beneficial ownership by acquiring 2,496 shares
• Form 4 filed and signed by an authorized representative, indicating compliance with Section 16 reporting

Negative

• None.

Insights

Financial Analyst

TL;DR: Small director acquisition recorded; ownership increased modestly to 3,833 shares.

The filing documents a non-derivative acquisition of 2,496 common shares by director Chris Koopmans on 08/14/2025, bringing his total beneficial holdings to 3,833 shares. The transaction is coded as an acquisition with a reported price of $0. Given the absolute share count, this is a limited change in insider exposure and is unlikely to move valuation metrics materially for investors tracking insider activity.

Corporate Governance Expert

TL;DR: Routine insider filing showing a director's purchase; procedural signature by POA on 08/15/2025.

The Form 4 indicates the reporting person is a director and the form was filed by one reporting person. The signature block shows the filing was executed by Jason T. Gray under power of attorney. The entry is straightforward and does not disclose additional governance actions or changes in board composition.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last) (First) (Middle)

C/O QORVO, INC.

7628 THORNDIKE ROAD

(Street)

GREENSBORO NC 27409

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Qorvo, Inc. [ QRVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2025		A		2,496	A	$0	3,833	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jason T. Gray, by Power of Attorney	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Chris Koopmans report for QRVO?

The Form 4 reports that director Chris Koopmans acquired 2,496 shares of Qorvo common stock on 08/14/2025, increasing his beneficial ownership to 3,833 shares.

What price was recorded for the QRVO share acquisition on the Form 4?

The transaction is reported with a recorded price of $0 on the Form 4.

Who filed and signed the Form 4 for QRVO insider activity?

The Form 4 shows it was signed on 08/15/2025 by /s/ Jason T. Gray, by Power of Attorney.

Does the Form 4 indicate a change in role for the reporting person at QRVO?

No. The filing lists the reporting person as a Director and does not indicate any change in relationship to the issuer.

How many shares does Chris Koopmans beneficially own after the reported transaction?

After the reported acquisition, Chris Koopmans beneficially owns 3,833 shares according to the Form 4.